Johnson & Johnson Receives Positive CHMP Opinion for Janssen’s Investigational Preventive Ebola...
An Ebovac2 poster was selected among 13 out of approx. 2 500 posters on the top rated of the...
The 7th newsletter is available here. This issue announces Ebovac2 4th annual meeting in Nairobi...
The 3rd EBOVAC1/2 Annual meeting will be held in Amsteram, the Netherlands 8-10 January 2018....
Based on final Phase 1 data published in JAMA: The Journal of the American Medical Association,...
What is Ebola?
Find out more about EBOVAC2 trials
EBOVAC2 is organised into 6 workpackages (WP)
Contributes to efforts to tackle a wide range of challenges in Ebola research
This project has received funding from the Innovative Medicines Initiative 2 Joint Undertaking under grant agreement No. 115861.
This Joint Undertaking receives support from the European Union’s Horizon 2020 research and innovation programme and EFPIA